Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 05 symbols : ABBV save search
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
Published: 2022-01-05 (Crawled : 16:00) - biospace.com/
MRK | $126.94 0.92% 0.0% 7.8M
|
Health Technology
|
| O: 0.32%
H: 3.3%
C: 2.1%
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
humira fda fda acceptance biosimilar
AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
conference
Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs
Published: 2022-01-05 (Crawled : 12:30) - vermillion.com
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
AWH | $3.49 0.71% 5.4K
|
Health Technology
|
| O: 2.34%
H: 5.71%
C: -8.57%
health women
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.